Relevance of MIC-1 in the Era of PSA as a Serum Based Predictor of Prostate Cancer: A Critical Evaluation

Abstract To reduce the ambiguity of contradictory observations in different studies regarding the expression level of Macrophage Inhibitory Cytokine-1 (MIC-1) in serum in prostate cancer (PC), benign prostatic hyperplasia (BPH) and healthy controls (HC), we designed this double-blind study. The stud...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Navneeta Bansal, Deepak Kumar, Ashish Gupta, Deepak Chandra, Satya Narain Sankhwar, Anil Mandhani
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3e65acf04b32411595ca1468f35a97f2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3e65acf04b32411595ca1468f35a97f2
record_format dspace
spelling oai:doaj.org-article:3e65acf04b32411595ca1468f35a97f22021-12-02T15:04:53ZRelevance of MIC-1 in the Era of PSA as a Serum Based Predictor of Prostate Cancer: A Critical Evaluation10.1038/s41598-017-17207-22045-2322https://doaj.org/article/3e65acf04b32411595ca1468f35a97f22017-12-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-17207-2https://doaj.org/toc/2045-2322Abstract To reduce the ambiguity of contradictory observations in different studies regarding the expression level of Macrophage Inhibitory Cytokine-1 (MIC-1) in serum in prostate cancer (PC), benign prostatic hyperplasia (BPH) and healthy controls (HC), we designed this double-blind study. The study comprises 240 sera from PC, BPH and HC subjects. The expression level of MIC-1 in PC, BPH and HC were appraised using Western blot (WB) and ELISA based approach. WB and ELISA appraisal reveals that the expression level of MIC-1 is significantly higher in PC than in HC or BPH subjects. Regression analysis revealed a significant correlation between MIC-1 vs. PSA (r = 0.09; p < 0.001) and MIC-1 vs. GS (r = 0.7; p < 0.001). ROC analysis using discriminant predicted probability revealed that the MIC-1 was better than PSA. Moreover, the combination of MIC-1 and PSA was allowing 99.1% AUC for the differentiation of BPH + PC from HC, 97.9% AUC for differentiation of BPH from HC, 98.6% AUC for differentiation of PC from HC, and 96.7% AUC for the differentiation of PC from BPH. The augmented expression of MIC-1 in PC compared to BPH and HC subjects is in concurrent of the over-expression of MIC-1 in PC reports and confiscates the contradictory findings of other studies.Navneeta BansalDeepak KumarAshish GuptaDeepak ChandraSatya Narain SankhwarAnil MandhaniNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-8 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Navneeta Bansal
Deepak Kumar
Ashish Gupta
Deepak Chandra
Satya Narain Sankhwar
Anil Mandhani
Relevance of MIC-1 in the Era of PSA as a Serum Based Predictor of Prostate Cancer: A Critical Evaluation
description Abstract To reduce the ambiguity of contradictory observations in different studies regarding the expression level of Macrophage Inhibitory Cytokine-1 (MIC-1) in serum in prostate cancer (PC), benign prostatic hyperplasia (BPH) and healthy controls (HC), we designed this double-blind study. The study comprises 240 sera from PC, BPH and HC subjects. The expression level of MIC-1 in PC, BPH and HC were appraised using Western blot (WB) and ELISA based approach. WB and ELISA appraisal reveals that the expression level of MIC-1 is significantly higher in PC than in HC or BPH subjects. Regression analysis revealed a significant correlation between MIC-1 vs. PSA (r = 0.09; p < 0.001) and MIC-1 vs. GS (r = 0.7; p < 0.001). ROC analysis using discriminant predicted probability revealed that the MIC-1 was better than PSA. Moreover, the combination of MIC-1 and PSA was allowing 99.1% AUC for the differentiation of BPH + PC from HC, 97.9% AUC for differentiation of BPH from HC, 98.6% AUC for differentiation of PC from HC, and 96.7% AUC for the differentiation of PC from BPH. The augmented expression of MIC-1 in PC compared to BPH and HC subjects is in concurrent of the over-expression of MIC-1 in PC reports and confiscates the contradictory findings of other studies.
format article
author Navneeta Bansal
Deepak Kumar
Ashish Gupta
Deepak Chandra
Satya Narain Sankhwar
Anil Mandhani
author_facet Navneeta Bansal
Deepak Kumar
Ashish Gupta
Deepak Chandra
Satya Narain Sankhwar
Anil Mandhani
author_sort Navneeta Bansal
title Relevance of MIC-1 in the Era of PSA as a Serum Based Predictor of Prostate Cancer: A Critical Evaluation
title_short Relevance of MIC-1 in the Era of PSA as a Serum Based Predictor of Prostate Cancer: A Critical Evaluation
title_full Relevance of MIC-1 in the Era of PSA as a Serum Based Predictor of Prostate Cancer: A Critical Evaluation
title_fullStr Relevance of MIC-1 in the Era of PSA as a Serum Based Predictor of Prostate Cancer: A Critical Evaluation
title_full_unstemmed Relevance of MIC-1 in the Era of PSA as a Serum Based Predictor of Prostate Cancer: A Critical Evaluation
title_sort relevance of mic-1 in the era of psa as a serum based predictor of prostate cancer: a critical evaluation
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/3e65acf04b32411595ca1468f35a97f2
work_keys_str_mv AT navneetabansal relevanceofmic1intheeraofpsaasaserumbasedpredictorofprostatecanceracriticalevaluation
AT deepakkumar relevanceofmic1intheeraofpsaasaserumbasedpredictorofprostatecanceracriticalevaluation
AT ashishgupta relevanceofmic1intheeraofpsaasaserumbasedpredictorofprostatecanceracriticalevaluation
AT deepakchandra relevanceofmic1intheeraofpsaasaserumbasedpredictorofprostatecanceracriticalevaluation
AT satyanarainsankhwar relevanceofmic1intheeraofpsaasaserumbasedpredictorofprostatecanceracriticalevaluation
AT anilmandhani relevanceofmic1intheeraofpsaasaserumbasedpredictorofprostatecanceracriticalevaluation
_version_ 1718389010446942208